| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advancing haematological research and clinical practice: a call for papers for ASH 2018
|
Collingridge, David
|
|
|
19 |
9 |
p. 1154
|
artikel
|
| 2 |
A new model for training in hybrid imaging
|
Hicks, Rodney J
|
|
|
19 |
9 |
p. 1152-1154
|
artikel
|
| 3 |
Apatinib and etoposide: surprising efficacy of an oral combination
|
Gourley, Charlie
|
|
|
19 |
9 |
p. 1146-1147
|
artikel
|
| 4 |
Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
|
Lan, Chun-Yan
|
|
|
19 |
9 |
p. 1239-1246
|
artikel
|
| 5 |
A physician's hand tumour induced by the first X-ray procedures
|
Benmoussa, Nadia
|
|
|
19 |
9 |
p. 1158
|
artikel
|
| 6 |
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study
|
Sun, Roger
|
|
|
19 |
9 |
p. 1180-1191
|
artikel
|
| 7 |
Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial
|
Cramer, Paula
|
|
|
19 |
9 |
p. 1215-1228
|
artikel
|
| 8 |
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial
|
van den Bent, Martin J
|
|
|
19 |
9 |
p. 1170-1179
|
artikel
|
| 9 |
Bevacizumab therapy for recurrent gliomas: another disappointment?
|
Gempt, Jens
|
|
|
19 |
9 |
p. 1137-1138
|
artikel
|
| 10 |
Blistering Langerhans cell histiocytosis
|
Chan, Melissa Mei Hsia
|
|
|
19 |
9 |
p. e500
|
artikel
|
| 11 |
Blood-based tumour mutational burden analysis in NSCLC
|
Das, Manjulika
|
|
|
19 |
9 |
p. e446
|
artikel
|
| 12 |
Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma
|
Vitolo, Umberto
|
|
|
19 |
9 |
p. 1144-1146
|
artikel
|
| 13 |
Brentuximab vedotin with gemcitabine for paediatric and young adult patients with relapsed or refractory Hodgkin's lymphoma (AHOD1221): a Children's Oncology Group, multicentre single-arm, phase 1–2 trial
|
Cole, Peter D
|
|
|
19 |
9 |
p. 1229-1238
|
artikel
|
| 14 |
Can radiomics personalise immunotherapy?
|
El Naqa, Issam
|
|
|
19 |
9 |
p. 1138-1139
|
artikel
|
| 15 |
CCR4-targeted therapy in cutaneous T-cell lymphoma
|
Gniadecki, Robert
|
|
|
19 |
9 |
p. 1140-1141
|
artikel
|
| 16 |
Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study
|
Steliarova-Foucher, Eva
|
|
|
19 |
9 |
p. 1159-1169
|
artikel
|
| 17 |
Choice of control group in randomised trials of cancer medicine: are we testing trivialities?
|
Tao, Derrick
|
|
|
19 |
9 |
p. 1150-1152
|
artikel
|
| 18 |
Correction to Lancet Oncol 2018; 19: 940–52
|
|
|
|
19 |
9 |
p. e440
|
artikel
|
| 19 |
Correction to Lancet Oncol 2018; 19: 1239–46
|
|
|
|
19 |
9 |
p. e440
|
artikel
|
| 20 |
Exercise as part of routine cancer care
|
Cormie, Prue
|
|
|
19 |
9 |
p. e432
|
artikel
|
| 21 |
Exercise as part of routine cancer care
|
Mina, Daniel Santa
|
|
|
19 |
9 |
p. e433-e436
|
artikel
|
| 22 |
HPV status and oesophageal adenocarcinoma
|
Stirrups, Robert
|
|
|
19 |
9 |
p. e443
|
artikel
|
| 23 |
Immune checkpoint inhibitors and cardiovascular toxicity
|
Lyon, Alexander R
|
|
|
19 |
9 |
p. e447-e458
|
artikel
|
| 24 |
Increasing incidence of cancer in children and competing risks
|
Autier, Philippe
|
|
|
19 |
9 |
p. 1136-1137
|
artikel
|
| 25 |
Intensified treatment for IKZF1-deleted childhood leukaemia
|
Burki, Talha Khan
|
|
|
19 |
9 |
p. e441
|
artikel
|
| 26 |
Is combining PARP and androgen receptor inhibition really a winning strategy in metastatic castration-resistant prostate cancer?
|
Di Nunno, Vincenzo
|
|
|
19 |
9 |
p. e437
|
artikel
|
| 27 |
Is combining PARP and androgen receptor inhibition really a winning strategy in metastatic castration-resistant prostate cancer? – Authors' reply
|
Clarke, Noel
|
|
|
19 |
9 |
p. e438
|
artikel
|
| 28 |
Meeting junior oncologists where they are: on their phones
|
Faust, Jeremy Samuel
|
|
|
19 |
9 |
p. 1155-1156
|
artikel
|
| 29 |
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
|
Kim, Youn H
|
|
|
19 |
9 |
p. 1192-1204
|
artikel
|
| 30 |
Monitoring asparaginase activity in middle-income countries
|
Cecconello, Daiane Keller
|
|
|
19 |
9 |
p. 1149-1150
|
artikel
|
| 31 |
New triple-negative breast cancer risk genes identified
|
Gourd, Elizabeth
|
|
|
19 |
9 |
p. e445
|
artikel
|
| 32 |
Oesophageal preservation in locally advanced oesophageal cancer
|
Ajani, Jaffer A
|
|
|
19 |
9 |
p. e430
|
artikel
|
| 33 |
Oesophageal preservation in locally advanced oesophageal cancer – Authors' reply
|
Noordman, Bo Jan
|
|
|
19 |
9 |
p. e431
|
artikel
|
| 34 |
Oncology, “fake” news, and legal liability
|
The Lancet Oncology,
|
|
|
19 |
9 |
p. 1135
|
artikel
|
| 35 |
One-stage direct-to-implant breast reconstruction using acellular dermal matrix
|
Benson, John R
|
|
|
19 |
9 |
p. 1141-1143
|
artikel
|
| 36 |
Problems in Medicare hospice provision
|
Burki, Talha Khan
|
|
|
19 |
9 |
p. e444
|
artikel
|
| 37 |
Quality of life and patient satisfaction after one-stage implant-based breast reconstruction with an acellular dermal matrix versus two-stage breast reconstruction (BRIOS): primary outcome of a randomised, controlled trial
|
Negenborn, Vera Lidwina
|
|
|
19 |
9 |
p. 1205-1214
|
artikel
|
| 38 |
Routine blood tests have low utility in lymphoma surveillance
|
Gourd, Elizabeth
|
|
|
19 |
9 |
p. e442
|
artikel
|
| 39 |
Seven minutes past midnight
|
De Ambrogi, Marco
|
|
|
19 |
9 |
p. 1157
|
artikel
|
| 40 |
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
|
Chekerov, Radoslav
|
|
|
19 |
9 |
p. 1247-1258
|
artikel
|
| 41 |
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review
|
Pe, Madeline
|
|
|
19 |
9 |
p. e459-e469
|
artikel
|
| 42 |
Targeted therapy: a potential oversight in trial protocol
|
Moorthy, Thurai
|
|
|
19 |
9 |
p. e439
|
artikel
|
| 43 |
The effect of natural disasters on cancer care: a systematic review
|
Man, Ralph Xiu-Gee
|
|
|
19 |
9 |
p. e482-e499
|
artikel
|
| 44 |
Treatment of platinum refractory or resistant ovarian cancer
|
Ferrandina, Gabriella
|
|
|
19 |
9 |
p. 1147-1149
|
artikel
|
| 45 |
Venetoclax in chronic lymphocytic leukaemia: a possible cure?
|
Kallam, Avyakta
|
|
|
19 |
9 |
p. 1143-1144
|
artikel
|
| 46 |
Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
|
Blackhall, Fiona
|
|
|
19 |
9 |
p. e470-e481
|
artikel
|
Tijdschrift beschrijving